Luye Pharma Group Ltd. - PE Ratio

The PE Ratio as of July 2026 (TTM) for Luye Pharma Group Ltd. (2186.HK) is 11.71

According to Luye Pharma Group Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 11.71. This represents a change of -0.39% compared to the average of 11.76 of the last 4 quarters.

Luye Pharma Group Ltd. (2186.HK) Historical PE Ratio (quarterly & annually)

How has 2186.HK PE Ratio performed in the past?

The mean historical PE Ratio of Luye Pharma Group Ltd. over the last ten years is 6.88. The current 11.71 PE Ratio has changed 16.93% with respect to the historical average. Over the past ten years (40 quarters), 2186.HK's PE Ratio was at its highest in in the December 2012 quarter at 33.07. The PE Ratio was at its lowest in in the December 2021 quarter at -4.84.

Luye Pharma Group Ltd. (2186.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Luye Pharma Group Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Luye Pharma Group Ltd. (2186.HK) Average PE Ratio

How has 2186.HK PE Ratio performed in the past?

The current PE Ratio of Luye Pharma Group Ltd. (2186.HK) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Luye Pharma Group Ltd. (2186.HK) PE Ratio vs. Peers

How is 2186.HK’s PE Ratio compared to its peers?

Luye Pharma Group Ltd.’s PE Ratio is greater than Consun Pharmaceutical Group Limited (9.11), less than Shanghai Haohai Biological Technology Co., Ltd. (31.47), greater than China Traditional Chinese Medicine Holdings Co. Limited (-17.67), greater than Alphamab Oncology (-60.87), less than Angelalign Technology Inc. (57.33), less than Beijing Chunlizhengda Medical Instruments Co., Ltd. (19.10), less than HBM Holdings Limited (23.09), less than Shandong Xinhua Pharmaceutical Company Limited (35.84), less than Kangji Medical Holdings Limited (16.21), less than Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (103.90),

Build a custom stock screener for Luye Pharma Group Ltd. (2186.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Luye Pharma Group Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Luye Pharma Group Ltd. (2186.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Luye Pharma Group Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.